{"id":"W2165791625","doi":"10.1093/eurheartj/ehu274","title":"Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society","year":2014,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1053,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Novo Nordisk Fonden; British Heart Foundation; Ontario Genomics Institute; Ontario Genomics; Regeneron Pharmaceuticals; F. Hoffmann-La Roche; Genome Canada; Canadian Institutes of Health Research; Danone; National Heart, Lung, and Blood Institute; Pfizer; Heart and Stroke Foundation of Canada; Valeant Pharmaceuticals International; Kowa Company; Sanofi; Amgen; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Position paper; Familial hypercholesterolemia; Position (finance); Atherosclerotic cardiovascular disease; Intensive care medicine; Internal medicine; Pathology; Cholesterol; Disease","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null}